PMDA posts MHLW notice directing revisions to drug package insert precautions (Mar 5, 2025)
使用上の注意の改訂指示通知（医薬品）2025年3月5日付（厚生労働省より発出）を掲載しました
Published: 2025-03-05 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Medium · First detected by this dashboard: 2026-08-06
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
The PMDA Safety Updates page lists a notice dated March 5, 2025, issued by the Ministry of Health, Labour and Welfare (MHLW), instructing revisions to the 'Precautions' (use precautions) sections of pharmaceutical product information. The metadata provided gives only the title and a generic page label; the specific drugs and revision details are not stated. This appears to be a government announcement posted on the PMDA site.
Business Impact
Marketing authorization holders and others handling the affected pharmaceuticals may need to consider whether their product labeling or safety information is affected. The scope and affected products cannot be determined from the metadata provided.
Recommended Action
Review the linked PMDA page and the underlying MHLW notice in Japanese to confirm which products are covered and what revisions are instructed.